CHM has multiple shots on goal with 4 clinical trials underway...

CHM has multiple shots on goal with 4 clinical trials underway and an exciting pre clinical pipeline….

Granted, the share price has been drifting down but rest assured management have loaded their guns as we approach AGM season.

take a look at ATX - some positive early results in a Phase 2A pancreatic cancer trial - partial responses for 5 patients.

CHM is targeting market segments that are 5+ times as big with potentially curative treatments. So imagine what would happen to the CHM share price if the company announced complete responses in the CDH17 gastric cancer trial or Advent AML trial.

It literally could be announced at any time in the next few months….Importantly clinical response in both the CDH17 and Advent AML is expected to happen early after treatment…within weeks….